Analysis of human HCT116 CRC cells demonstrated that they have a mutated type II TGF-β receptor gene and cannot respond to TGF-β in order to undergo EMT, invasion, or migration [58]. This evidence concerns the gene TGFB1 and colorectal carcinoma.